Pcmb is a tiny company outsourcing most of its work and hasn’t borrowed to do so.
Bio takes many years to succeed and this disruptive technology and its development are no exception.
But we are very very close to ind submission.
We have never been closer.
Getting impatient doesn’t solve anything.
They want to get it right. Kw has shown some inexperience but overall the recent progress has been very impressive and we are almost there with submitting our ind for this very complex and emerging technology for which the fda has only recently had regulations.
I’m a patient believer.
Because I think ind submission will bring funding and even a partnership. There are so many rich pc foundations who will want to fund this with a doctor like Manuel Hidalgo in charge of the trials and a hope for an unmet medical need for pancreatic cancer patients who have run out of options and otherwise face a certain death.
This is screaming breakthrough technology to me.
I continue to be impressed by the many investors on here who have lost loved ones to pancreatic cancer and their hope for others to have a technology to save new lives.
And first results will be available after four weeks of treatment.
It’s going to be a very good Christmas for those who have been patient imho. And for pancreatic cancer patients.
It’s been very frustrating watching the mms stop this from achieving its true value but that will stop when news of the successful ind and the first trial results are announced and new investors flood into this stock.
It’s not easy being patient. How much more patient have Crabtree and Waggoner been though?
News 
Market Data 
Discover 
